Cancer Diagnostics Market Detailed Analysis with Accurate Forecast to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables (Antibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing, imaging, and biopsy technology), Application (Breast Cancer, Lung Cancer), End User (Hospitals)- Market Outlook And Industry Analysis 2031"

The global Cancer Diagnostics market is estimated to reach over USD 300.79 billion by 2031, exhibiting a CAGR of 7.16% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1726

Global healthcare systems are under unprecedented stress as a result of COVID-19. It has made it challenging to provide care while limiting virus spread, and it has increased the demand for hospital resources. Global healthcare systems have found adapting to the COVID-19 pandemic's problems difficult. So, since the epidemic started, surgeons have observed a drop in the number of elective surgeries performed. This postponement of non-urgent elective surgeries has an impact on planned oncology procedures. Tumor patients are particularly vulnerable to infection.

Moreover, patients with cancer have higher COVID-19 morbidity and mortality rates. According to the American Society of Clinical Oncology's study, there was a significant drop in biopsies, tumour screens, office visits, therapy, and surgeries from March to July 2020 compared to 2019. Cancer screenings for colon, breast, lung, and prostate were 75%, 85%, 56%, and 74% lower in April 2020, when the pandemic was at its worst. Also, the COVID-19 pandemic caused the cancellation of almost 800 appointments for the screening of lung cancer in just March 2020. The ratio of new patients screening remained low even after the screening returned to its regular frequency.

List of Prominent Players in the Cancer Diagnostics Market:
• Abbott Laboratories,
• Agilent Technologies Inc.,
• AMOY Diagnostics Co Ltd.,
• Astellas Pharma Inc. (Japan)
• BD
• BiocartisNV,
• bioMérieux SA (France)
• Bristol-Myers Squibb Company (U.S.)
• Cancer Diagnostics Inc.,
• Danaher Corporation,
• DiagnoCure Inc. (Canada)
• DiaSorin S.P.A.,
• Excat Science
• F. Hoffmann-La Roche Ltd.
• FUJIFILM Corporation,
• GE Healthcare
• Genomic Health, Inc. (U.S.)
• GSK plc. (U.K.)
• Hologic, Inc.
• Illumina, Inc.
• Koninklijke Philips N.V. (Philips)
• Lilly (U.S.)
• Merck KGaA, (Germany)
• Myriad Genetics Inc.,
• Novartis AG (Switzerland)
• Pfizer, Inc. (U.S.)
• Qiagen N.V.
• Quest Diagnostics Incorporated. (U.S.)
• Quidel Corporation,
• Roche Diagnostics,
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers-
Technological developments in diagnostic testing are anticipated to fuel market expansion throughout the forecast period. For instance, Hologic, Inc. declared that the Genius Digital Diagnostics System would be commercially available in Europe starting in 2021. The next-generation cervical cancer screening system uses new volumetric imaging technology and deep learning-based AI to help find women with precancerous lesions and cervical cancer cells. This should accelerate market growth.

Challenges:
Many hospitals in undeveloped and impoverished countries are unable to purchase diagnostic imaging equipment due to high costs and financial restrictions. Yet, due to the rising demand in these nations for diagnostic imaging procedures, hospitals that cannot afford to purchase brand-new, cutting-edge imaging systems favour rebuilt ones. As a result, this factor inhibits market expansion.

Regional Trends:
Due to strategic moves made by major players, a significant increase in cervical screening programmes run to improve awareness and screening, a rise in R&D, and technical advancements, Asia Pacific is predicted to have the quickest growth throughout the projection period. For instance, National Cervical Cancer Awareness Week 2019 was introduced by the Australian Cervical Cancer Foundation (ACCF) in November 2019. The ACCF wants to raise awareness among women all throughout Australia in order to eradicate cervical cancer by the year 2035. One of the companies supporting the ACCF screening programmes is Hologic Inc.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1726

Recent Developments:
• In November 2021, Magnetom Free was introduced by Siemens Healthineers. The Star whole-body MRI scanner was created to dramatically improve access to magnetic resonance imaging on a global scale.

Segmentation of Cancer Diagnostics Market-
By Product-
• Consumables
o Antibodies
o Kits & Reagents
o Probes
o Others
• Instruments
o Pathology based Instrument
o Slide Staining Systems
o Tissue Processing Systems
o Cell Processors
o PCR Instruments
o NGS Instruments
o Microarrays
o Other Pathology-based Instruments
o Imaging Instruments
o CT Systems
o Ultrasound Systems
o MRI Systems
o Mammography Systems
o Nuclear Imaging Systems
• Biopsy Instruments
By Technology-
• IVD Testing
o Polymerase Chain Reaction (PCR)
o In Situ Hybridization (ISH)
o Immunohistochemistry (IHC)
o Next-generation Sequencing (NGS)
o Microarrays
o Flow Cytometry
o Immunoassays
o Others
• Imaging
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT)
o Positron Emission Tomography (PET)
o Mammography
o Ultrasound
• Biopsy Technique
By Application-
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Others
By End User-
• Hospitals
• Diagnostics Laboratories
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.